Display options
Cite
Fronczak A, Jasińska A, Biernacka EK. Expanded indications for transcatheter renal denervation. Postepy Kardiol Interwencyjnej. 2013;9(3):291-3doi: 10.5114/pwki.2013.37512.
Fronczak, A., Jasińska, A., & Biernacka, E. K. (2013). Expanded indications for transcatheter renal denervation. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 9(3), 291-3. https://doi.org/10.5114/pwki.2013.37512
Fronczak, Aneta, et al. "Expanded indications for transcatheter renal denervation." Postepy w kardiologii interwencyjnej = Advances in interventional cardiology vol. 9,3 (2013): 291-3. doi: https://doi.org/10.5114/pwki.2013.37512
Fronczak A, Jasińska A, Biernacka EK. Expanded indications for transcatheter renal denervation. Postepy Kardiol Interwencyjnej. 2013;9(3):291-3. doi: 10.5114/pwki.2013.37512. Epub 2013 Sep 16. PMID: 24570735; PMCID: PMC3915992.
Copy Download .nbib Format: NLM
Share it on

Postepy Kardiol Interwencyjnej. 2013;9(3):291-3. doi: 10.5114/pwki.2013.37512. Epub 2013 Sep 16.

Expanded indications for transcatheter renal denervation.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

Aneta Fronczak, Anna Jasińska, Elżbieta Katarzyna Biernacka

Affiliations

  1. Students' Scientific Group "Heart Rhythm", Medical University of Warsaw, Poland.
  2. Institute of Cardiology, Warsaw, Poland.

PMID: 24570735 PMCID: PMC3915992 DOI: 10.5114/pwki.2013.37512

Abstract

Renal denervation (RDN) is a catheter-based procedure introduced in 2009 as a treatment of resistant hypertension. The method is based on the concept that resistant hypertension is a result of hyperactivity of the sympathetic nervous system (SNS), and therefore reducing the impact of the SNS by ablating the renal nerves should eliminate the condition. Since 2009 numerous investigators have proven the procedure to be safe and effective, which contributed to the quick success and wide spread of the method, subsequently triggering further research in this area. The dynamic distribution of the procedure induced investigators to examine the influence of RDN on other conditions involving hyperactivity of the SNS (such as atrial fibrillation or ventricular arrhythmia). A few studies aiming to explain the influence of RDN on arrhythmias in patients with resistant hypertension have been conducted. The results in treating atrial fibrillation additionally to pulmonary vein ablation and electrical storm appear to be promising; however, the data are limited and further investigations needs to be done. The influence of RDN on insulin resistance, left ventricular hypertrophy and heart failure are possible. Perspectives of expanding indications are discussed. Renal denervation appears to be a promising way of treating hypertension and raises hope for a wider group of patients with conditions closely related to hyperactivity of the sympathetic nervous system such as arrhythmia.

Keywords: atrial fibrillation; renal denervation; ventricular arrhythmia

References

  1. Heart Rhythm. 2009 Jun;6(6):752-9 - PubMed
  2. Circulation. 2012 Dec 18;126(25):2976-82 - PubMed
  3. EuroIntervention. 2013 May;9 Suppl R:R110-6 - PubMed
  4. Circulation. 1990 Aug;82(2 Suppl):I103-13 - PubMed
  5. Hypertension. 1999 Oct;34(4 Pt 2):724-8 - PubMed
  6. Clin Res Cardiol. 2012 Jan;101(1):63-7 - PubMed
  7. Circ Res. 1987 Jun;60(6):942-51 - PubMed
  8. Physiol Rev. 2011 Jan;91(1):265-325 - PubMed
  9. Hypertension. 2011 May;57(5):911-7 - PubMed
  10. J Am Coll Cardiol. 2012 Mar 6;59(10):901-9 - PubMed
  11. Am J Med. 1995 May;98(5):476-84 - PubMed
  12. Circulation. 1998 Sep 8;98(10):946-52 - PubMed
  13. Cleve Clin J Med. 2008 Mar;75 Suppl 2:S94-6 - PubMed
  14. J Am Coll Cardiol. 2012 Sep 25;60(13):1163-70 - PubMed
  15. Hypertension. 2013 Jan;61(1):225-31 - PubMed
  16. J Korean Med Sci. 2013 Jun;28(6):951-4 - PubMed
  17. Lancet. 2009 Apr 11;373(9671):1275-81 - PubMed

Publication Types